About Index Trending news
Analyze
Pricing
Advent Life Sciences LLP

Advent Life Sciences LLP

Work at Advent Life Sciences LLP? Add yourself to this profile

Advent Life Sciences LLP

Elsewhere

Alexa global traffic share

Investment profile

Target markets
Financial Services Life Sciences

Activity

Past year's investments

- Advent Life Sciences participated in 6 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $205,895,062 (averaging $34,315,844 per round).

Latest rounds

- Iterum Therapeutics: Venture capital (Series B) ($65M)
- Axonics Modulation Technologies: Venture capital (Series C) ($14.5M)
- Vestagen Technical Textiles Inc.: Venture capital ($10M)

Main Co-investors

- Neomed Management
- HealthQuest Capital
- Osage University Partners

Total funding
$104M in 3 rounds from 11 investors
By Advent Life Sciences
$75M Series C in Mar, 2016
Total funding
$106.1M in 4 rounds from 15 investors
By Advent Life Sciences
$14.5M Series C in May, 2017
Total funding
$33M in 3 rounds from 7 investors
By Advent Life Sciences
$21M Series B in Mar, 2015
Total funding
$119.5M in 5 rounds from 18 investors
By Advent Life Sciences
$55M Series E in Feb, 2014
Total funding
$17M in 2 rounds from 5 investors
By Advent Life Sciences
$10M Venture Capital in Apr, 2017
Total funding
$15.3M in 1 rounds from 3 investors
By Advent Life Sciences
£11M Series A in Mar, 2016
Total funding
$105M in 2 rounds from 13 investors
By Advent Life Sciences
$65M Series B in May, 2017
Total funding
$60M in 1 rounds from 8 investors
By Advent Life Sciences
$60M Venture Capital in Jun, 2016
Total funding
$46.8M in 2 rounds from 8 investors
By Advent Life Sciences
£23M Series B in Jan, 2017
Total funding
$38M in 1 rounds from 6 investors
By Advent Life Sciences
$38M Series A in Feb, 2017
Total funding
$84.8M in 3 rounds from 8 investors
By Advent Life Sciences
$50M Series C in Mar, 2017

Want to see the complete list?
Go Pro!